United Therapeutics Corp revenue increases to $506.90 million in quarter ended Mar 31, 2023 from previous quarter
By USInMinutes - May 03, 2023, 08:33 AM ET
Last Updated - Jul 18, 2023, 03:43 PM EDT
Key fundamental financials
profit of $240.90 million
Revenue of $506.90 million
earnings per share of $4.86
Current Reporting
Revenue
Net Income
Profit/Loss
Mar 2023
$506.90 million
$240.90 million
profit
Sep 2022
$516
$239.30
profit
Jun 2022
$466.90 million
$116 million
profit
United Therapeutics Corp [UTHR] has reported $240.90 million profit for the fiscal quarter ending Mar 31, 2023 while the earnings for the same period were $4.86 per share.
Revenue for the quarter was $506.90 million with operating income of $284.40 million.
The Silverspring, Maryland (MD)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $5,123.20 million.
